ReviewJournal of clinical medicine2025

Assessment of Chemo-Immunotherapy Regimens in Patients with Refractory or Relapsed Neuroblastoma: A Systematic Review with Meta-Analysis of Critical Oncological Outcomes.

Nur Olgun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.